Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-24-073145

CEO bought 100,000 shares at $1.17 ($117,430)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Spoor Johan M. CEO 2024-06-13 Purchase +100,000 $1.17 $117,430 137,572 D
Open-market purchases · 100,000 sh · avg $1.17 · $117,430
Loading xslF345X05/ownership.xml…